UK History professor and Pulitzer Prize nominated author Tracy A. Campbell's latest book, "The Gateway Arch: A Biography," explores the political and economic history of St. Louis and the origins of the city's most recognized structure. Campbell also serves as co-director of UK's Wendell H. Ford Public Policy Research Center.
At the University of Kentucky, Assistant Professor of Chemistry Edith "Phoebe" Glazer is looking for something more effective at killing cancer cells and less toxic to healthy cells than cisplatin. A platinum-based drug, cisplatin is one of the most commonly used cancer drugs, but leads to nausea and nerve damage. Her alternative uses ruthenium, another transition metal, to build complex molecules. Theses molecules can be "switched on" by light from a fiber-optic probe once they reach their target tumor and would kill only cancerous cells. In January 2013, Glazer received a four-year, $715,000 grant from the American Cancer Society to develop a family of ruthenium molecules to fight different kinds of cancer.